Abstract:Background: To analyze the efficacy of computed tomography (CT)-guided implantation of I-125 radioactive particles in treatment of early lung cancer. Methods: Six patients were analyzed, including 4 squamous cell carcinoma, 1 adenocarcinoma, and 1 small cell lung cancer. TPS software was used to calculate the therapeutic dose amount of particles implanted, and the spacing and distribution of seeds in the target area and adjacent tissues. Under the guidance of CT, 20-55 particles were implanted at each site, with the total number of radioactive particles being 226, the particle spacing being 0.5-1.0 cm, and the implantation being performed in accordance with the principle of uniform implantation. The patients were each followed up with repeated pulmonary CT scans at 1, 3, 6, 12, 18, 24, 30 and 36 months after the procedure. In accordance with the response evaluation criteria in solid tumors (RECIST), the following definitions for responses were used: complete response (CR), partial response (PR), stable disease (SD), progressive disease (PD). Results: There were 2 CRs and 4 PRs one month after procedure; six patients were followed up 3 months after procedure, including 2 CRs and 4 PRs; one patient was lost in follow-up, and 5 patients were followed up 6 months after procedure, including 3 CRs and 2 PRs; five patients were followed up 12 months after procedure, including 3 CRs, 1 PR and 1 PD. The single PD patient was again given CT-guided implantation of 125I radioactive particles for the treatment of recurrent lesions. The pulmonary CT was repeated 6 months after procedure, and the response was evaluated as SD. Four patients were followed up 18 months after procedure, including 3 CRs and 1 PR; one patient was lost in follow-up and 3 patients were followed up 24 months after the procedure with the response being evaluated as CR for all of them; one patient was followed up 36 months after procedure, and the response was evaluated as PD. During the follow-up, no serious complications occurred in any of the patients. Conclusions: The preliminary clinical observation showed that 125I radioactive particle implantation was a safe, reliable and effective therapeutic method for early lung cancer.

The efficacy and safety of percutaneous CT-guided iodine-125 brachytherapy combined with standard chemotherapy and brachytherapy alone for lung malignant nodule: a retrospective comparative cohort study

Brachytherapy by Percutaneous Paracentesis Implantation of Iodine-125 Seeds for Lung Cancer

CT-MPR Guides Percutaneous Brachytherapy Easily for Hepatic Carcinoma and Extrahepatic Metastases

Preliminary Clinical Efficacy of Iodine-125 Seed Implantation for the Treatment of Advanced Malignant Lung Tumors

Safety and Effectiveness Analysis of Percutaneous Microwave Thermal Ablation Therapy Combined Brachytherapy for Lung Malignant Lesion

125I Brachytherapy of Locally Advanced Non-Small-cell Lung Cancer after One Cycle of First-Line Chemotherapy: a Comparison with Best Supportive Care.

Computed Tomography Fluoroscopy-Guided Percutaneous 125I Seed Implantation for Safe, Effective and Real-Time Monitoring Radiotherapy of Inoperable Stage T1-3N0M0 Non-Small-cell Lung Cancer.

CT-guided iodine-125 brachytherapy is an effective palliative treatment for the right lower paratracheal lymph nodes metastasis previously treatment failure

Efficacy and safety of iodine-125 radioactive seeds brachytherapy for advanced non–small cell lung cancer—A meta-analysis

The efficacy and safety of <SUP>125</SUP>I brachytherapy combined with pre-operative transarterial chemoembolization in patients with locally advanced head and neck cancer

Therapeutic Effect of CT-guided 125I Seed Implantation on Advanced Lung Cancer and Pulmonary Metastatic Carcinoma

CT-guided Percutaneous Implantation of 125I Particles in Treatment of Early Lung Cancer

Iodine-125 Interstitial Brachytherapy Reduces Tumor Growth Via Warburg Effect Inhibition in Non-Small Cell Lung Cancer A549 ×Enografts.

Radiation Physics, Quality Control, and Quality Assurance of Lung Cancer Brachytherapy with 125I Particles

Implantation of Computed Tomography-Guided Iodine-125 Seeds in Combination with Chemotherapy for the Treatment of Stage III Non-Small Cell Lung Cancer

Preliminary Results of a Phase 1/2 Study of Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination with Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non–small Cell Lung Canc

Efficacy of Brachytherapy Concomitant with Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil in Unresectable Head and Neck Squamous Cell Carcinoma.

Clinical efficacy and prognostic factors of CT-guided radioactive iodine-125 seed implantation for the treatment of superficial soft tissue metastasis: a 12-year retrospective analysis

Dosimetric Evaluation of Iodine-125 Brachytherapy for Tumour Size < 5cm NSCLC Patients

I-125 Inhibited the NSCLC Both in Vivo and in Vitro

CT-guided radioactive 125I seeds brachytherapy for lung oligometastases from colorectal cancer: initial results